Insight into the Role of the PI3K/Akt Pathway in Ischemic Injury and Post-Infarct Left Ventricular Remodeling in Normal and Diabetic Heart
Open accessThe DOI matches its Crossref record; 334 of the 340 references it cites were found in a registry or an index.
Abstract
Despite the significant decline in mortality, cardiovascular diseases are still the leading cause of death worldwide. Among them, myocardial infarction (MI) seems to be the most important. A further decline in the death rate may be achieved by the introduction of molecularly targeted drugs. It seems that the components of the PI3K/Akt signaling pathway are good candidates for this. The PI3K/Akt pathway plays a key role in the regulation of the growth and survival of cells, such as cardiomyocytes. In addition, it has been shown that the activation of the PI3K/Akt pathway results in the alleviation of the negative post-infarct changes in the myocardium and is impaired in the state of diabetes. In this article, the role of this pathway was described in each step of ischemia and subsequent left ventricular remodeling. In addition, we point out the most promising substances which need more investigation before introduction into clinical practice. Moreover, we present the impact of diabetes and widely used cardiac and antidiabetic drugs on the PI3K/Akt pathway and discuss the molecular mechanism of its effects on myocardial ischemia and left ventricular remodeling.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the cardiovascular system, GLP-1 can reduce cardiac ischemia-reperfusion injury through the activation of specific signaling pathways, such as the PI3K/Akt pathway.437,438”
From Glucagon-like peptide-1 receptor: mechanisms and advances in therapy (2024) · cites this paper as [437]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
4 retracted
Items 201–334 of 334
Sánchez-Ceinos, J., Rangel-Zúñiga, O. A., Clemente‐Postigo, M., Podadera-Herreros, A., Camargo, A., Alcala-Diaz, J. F., Guzmán‐Ruiz, R., López‐Miranda, J., & Malagón, M. M. (2021) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2021.01.014 · Cited by 72
Bergmann, M. W., Rechner, C., Freund, C. M. A. H., Baurand, A., Jamali, A. E., & Dietz, R. (2004) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2004.05.025 · Cited by 71
Expression and DNA methylation status of microRNA-375 in patients with type 2 diabetes mellitus
Sun, K., Chang, X., YIN, L., Li, J., Zhou, T., Zhang, C., & Chen, X. (2013) · Molecular Medicine Reports · doi:10.3892/mmr.2013.1872 · Cited by 71 · cited 1×
“miR-375 up [323,324] Exacerbates inflammation and cardiomyocyte apoptosis, decreases angiogenesis and impairs the LV function after MI by a reduction in PDK-1 expression, which results in decreased Akt Thr-308 phosphorylation [325,326].”
BackgroundMultiple death pathways in TNF-treated fibroblasts: RIP3- and RIP1-dependent and independent routes
Zhang, D., Zheng, M., Zhao, J., Li, Y.-Y., Huang, Z., Li, Z., & Han, J. (2011) · Cell Research · doi:10.1038/cr.2011.3 · Cited by 70
Li, C., & Li, Y. (2015) · Cardiology Research and Practice · doi:10.1155/2015/698368 · Cited by 70 · cited 1×
“showed that the appropriate regulation of the PI3K/Akt pathway by inhibiting its excessive activity reduces the abnormal excitability, automatism, and conductivity of residual myocytes, which result in the initiation of arrhythmia after myocardial infarction in rats [229,230].”
BackgroundZhu, Y., Qian, X., Li, J., Lin, X., Luo, J.-W., Huang, J., & Zhao, J. (2019) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2019.1687492 · Cited by 70 · cited 1×
“miR-34 up [294] Inhibition of miR-34a attenuates MI-induced LV remodeling in mice and induces Akt phosphorylation [298]; activates PI3K/AKT pathways via up-regulating ZEB1 in cardiomyocytes and attenuates hypoxia-induced injury [299]; protects H9C2 cardiomyocytes from high-glucose-induced injury [300].”
BackgroundYin, X., Zheng, Y., Zhai, X.-J., Zhao, X., & Cai, L. F. (2011) · Experimental Diabetes Research · doi:10.1155/2012/198048 · Cited by 69 · cited 1×
“DM inhibits preconditioning and postconditioning, affecting PI3K/Akt on many levels [122,242].”
BackgroundCardiac Conduction Velocity, Remodeling and Arrhythmogenesis
Han, B., Trew, M. L., & Zgierski-Johnston, C. M. (2021) · Cells · doi:10.3390/cells10112923 · Cited by 69
Chien, H.-Y., Lee, T.-P., Chen, C.-Y., Chiu, Y.-H., Lin, Y.-C., Lee, L.-S., & Li, W. (2014) · Journal of the Chinese Medical Association · doi:10.1016/j.jcma.2014.11.002 · Cited by 68
Teshima, S., Nakanishi, H., Nishizawa, M., Kitagawa, K., Kaibori, M., Yamada, M., Habara, K., Kwon, A., Kamiyama, Y., Ito, S., et al. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2003.12.018 · Cited by 68
Liang, D., Zhong, P., Hu, J., Lin, F., Qian, Y., Xu, Z., Wang, J., Zeng, C., Li, X., & Liang, G. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.02.029 · Cited by 67 · cited 1×
“This results in ROS generation and cardiac damage which can be decreased by EGFR inhibitors [258].”
BackgroundRobinson, E., Cassidy, R. S., Tate, M., Zhao, Y., Lockhart, S., Calderwood, D., Church, R., McGahon, M. K., Brazil, D. P., McDermott, B. J., et al. (2015) · Basic Research in Cardiology · doi:10.1007/s00395-015-0476-7 · Cited by 67 · cited 1×
“showed that the infusion of exendin-4 for 4 weeks after MI can improve survival and protect against cardiac dysfunction [266].”
BackgroundTargeting necroptosis as therapeutic potential in chronic myocardial infarction
Piamsiri, C., Maneechote, C., Siri‐Angkul, N., Chattipakorn, S. C., & Chattipakorn, N. (2021) · Journal of Biomedical Science · doi:10.1186/s12929-021-00722-w · Cited by 67 · cited 1×
“In addition, it is one of the key pathways in the loss of functional cardiomyocytes during MI [89,90].”
BackgroundYu, P., Ma, S., Dai, X., & Cao, F. (2020) · PubMed · Cited by 66
The Caspase 1 Inhibitor VX-765 Protects the Isolated Rat Heart via the RISK Pathway
do Carmo, H. R. P., Arjun, S., Petrucci, O., Yellon, D. M., & Davidson, S. M. (2018) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-018-6781-2 · Cited by 66
Lei, S., Su, W., Xia, Z., Wang, Y., Zhou, L., Qiao, S., Zhao, B., Xia, Z., & Irwin, M. G. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/9836302 · Cited by 66 · cited 1×
“This effect may be caused by high glucose-dependent oxidative stress, which abrogates remifentanil preconditioning in STZ-induced diabetic rats [244].”
BackgroundLamblin, N., Fertin, M. J., de Groote, P., & Bauters, C. (2012) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0b013e328353694b · Cited by 64 · cited 1×
“Among patients with first anterior MI, DM was associated with a greater risk of cardiovascular death or rehospitalization for HF [249].”
BackgroundSong, W., Liang, Q., Cai, M., & Tian, Z. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15892 · Cited by 64 · cited 1×
“Further study on human umbilical vein endothelial cells (HUVECs) suggests that miR-126 may be involved in tube formation under hypoxia through the PI3K/AKT/eNOS pathway [278].”
BackgroundQiao, S., Olson, J. M., Paterson, M., Yan, Y., Zaja, I., Liu, Y., Riess, M. L., Kersten, J. R., Liang, M., Warltier, D. C., et al. (2015) · Anesthesiology · doi:10.1097/aln.0000000000000807 · Cited by 63 · cited 1×
“Loss of miR-21 reverses all these beneficial effects and can also reverse the cardioprotective effect of isoflurane preconditioning, which is associated with increased phosphorylation of Akt and eNOS [275].”
BackgroundIdentification of Novel in Vivo Phosphorylation Sites of the Human Proapoptotic Protein BAD
Polzien, L., Baljuls, A., Rennefahrt, U. E. E., Fischer, A., Schmitz, W., Zahedi, R. P., Sickmann, A., Metz, R., Albert, S., Benz, R., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.010702 · Cited by 63
Ma, N., Bai, J., Zhang, W., Luo, H., Zhang, X., Liu, D., & Qiao, C. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5773 · Cited by 63 · cited 1×
“Moreover, mir-21-induced activity of Akt signaling decreases the Bax/Bcl-2 ratio and expression of caspase-3, which can inhibit apoptosis of human H9C2 cardiomyocytes and lead to a reduction in the infarct size in the SD rats IRI model [271,272].”
BackgroundBäcklund, T., Palojoki, E., Saraste, A., Eriksson, A., Finckenberg, P., Kytö, V., Lakkisto, P., Mervaala, E., Voipio-Pulkki, L., Laine, M., et al. (2004) · Diabetologia · doi:10.1007/s00125-003-1311-5 · Cited by 61
Yu, L., Li, Z., Dong, X., Xue, X., Liu, Y., Xu, S. C., Zhang, J., Han, J., Yang, Y., & Wang, H. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/2750695 · Cited by 61 · cited 1×
“The impact of the PI3K/Akt signal on the Notch1/Hes1 pathway and its beneficial effect on the diabetic myocardium after IRI was also presented by other researchers [240].”
BackgroundFeng, Q., Li, X., Qin, X., Cheng, Y., Jin, Y. J., & Qian, X. (2020) · Molecular Medicine · doi:10.1186/s10020-020-00241-8 · Cited by 61 · cited 5×
“a reduction in the number of cardiomyocytes undergoing apoptosis in the infarcted tissue compared with the myocardium where this pathway is inhibited [61,62,65].”
BackgroundInfluentialCardiac Remodelling and Myocardial Recovery: Lost in Translation?
Mann, D. L., Bogaev, R. C., & Buckberg, G. D. (2010) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfq113 · Cited by 59 · cited 1×
“Such structural changes are associated with increased cardiomyocyte apoptosis and fibrosis and result in contractile dysfunction, dilatation, and consequently, the development of HF [207,208].”
BackgroundParajuli, N., Yuan, Y., Zheng, X., Bedja, D., & Cai, Z. P. (2012) · Basic Research in Cardiology · doi:10.1007/s00395-012-0248-6 · Cited by 59 · cited 1×
“demonstrated that PTEN regulates the expression of important pro-inflammatory cytokines through the PI3K/Akt/IL-10/TNF-α signaling pathway and thus plays a significant role in post-MI remodeling of the myocardium in mice [164].”
BackgroundKui, L., Weiwei, Z., ling, L., Daikun, H., Guoming, Z., Linuo, Z., & Ren-ming, H. (2009) · Regulatory Peptides · doi:10.1016/j.regpep.2009.03.003 · Cited by 59 · cited 1×
“This promotes phosphorylation of both Akt and ERK1/2 and the nuclear translocation of NFκB, which promotes anti-apoptotic BCL-2 and Bcl-xL expression [236].”
BackgroundAnand, I. S., Florea, V. G., Solomon, S. D., Konstam, M. A., & Udelson, J. E. (2002) · Journal of Cardiac Failure · doi:10.1054/jcaf.2002.129286 · Cited by 58
Meng, H., Zhang, Y., An, S., & Chen, Y. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27717 · Cited by 58 · cited 1×
“Its activity provides cardioprotection and promotes the repair and healing of myocardial cells after MI [141].”
BackgroundChen, Q., Xu, T., Li, D., Pan, D., Wu, P., Luo, Y., Ma, Y., & Liu, Y. (2016) · Europe PMC (PubMed Central) · Cited by 57
Circulating MicroRNA-145 is Associated with Acute Myocardial Infarction and Heart Failure
Zhang, M., Cheng, Y., Sara, J. D. S., Liu, L., Liu, L., Zhao, X., & Gao, H. (2017) · Chinese Medical Journal · doi:10.4103/0366-6999.196573 · Cited by 56
Effect of diabetes on exosomal miRNA profile in patients with obesity
Kim, H., Bae, Y., Lee, H., Kim, H., Jeon, J. S., Noh, H., Han, D. C., Byun, D. W., Kim, S. H., Park, H. K., et al. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001403 · Cited by 56 · cited 3×
“miR-130 up [295,309,310] Attenuates LV dysfunction and remodeling after MI targeting PTEN and increasing activity of Akt [311]”
BackgroundGomes, J. L. P., Fernandes, T., Soci, U. P. R., Silveira, A. C., Barretti, D. L. M., Negrão, C. E., & Oliveira, E. M. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/2415246 · Cited by 55
Yuan, Y., Wang, J., Chen, Q., Wu, Q., Deng, W., Zhou, H., & Shen, D. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.02.014 · Cited by 54 · cited 1×
“miR-155 up [313,314] Targets IKKi expression decreasing its cardioprotective role in activating Akt and NF-κB, independent of the PI3K, and enhances cardiac hypertrophy [315], inhibits the AKT/CREB pathway signal and impairs the left ventricle function [316].”
BackgroundLassen, T. R., Just, J., Hjortbak, M. V., Jespersen, N. R., Stenz, K. T., Gu, T., Yan, Y., Su, J., Hansen, J., Bæk, R., et al. (2021) · Basic Research in Cardiology · doi:10.1007/s00395-021-00856-w · Cited by 54 · cited 1×
“showed that EVs from the plasma of healthy human volunteers after RIC may not only provide cardioprotection via increasing mTOR expression, but also demonstrate accumulation in the damaged myocardium compared with sham-operated hearts [130].”
BackgroundRoles of ferroptosis in urologic malignancies
Zhao, S., Li, P., Wu, W., Wang, Q., Qian, B., Li, X., & Shen, M. (2021) · Cancer Cell International · doi:10.1186/s12935-021-02264-5 · Cited by 54 · cited 1×
“The PI3K/Akt pathway has been shown to play a significant role in its regulation [101].”
BackgroundThe Cardioprotective Effect of Protocatechuic Acid on Myocardial Ischemia/Reperfusion Injury
Tang, X., Liu, J., Dong, W., Li, P., Li, L., Lin, C.-R., Zheng, Y., Cong, W., & Hou, J.-C. (2014) · Journal of Pharmacological Sciences · doi:10.1254/jphs.13247fp · Cited by 52 · cited 1×
“a reduction in the number of cardiomyocytes undergoing apoptosis in the infarcted tissue compared with the myocardium where this pathway is inhibited [61,62,65].”
BackgroundRosselló, X., Riquelme, J. A., Davidson, S. M., & Yellon, D. M. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13394 · Cited by 52 · cited 2×
“PI3K activity is required during both the pre-ischemic trigger phase and the post-ischemic mediator phase of IC to reduce infarct size and mortality [121,122].”
BackgroundStatistics on mortality following acute myocardial infarction in 842 897 Europeans
Alabas, O., Jernberg, T., Pujades‐Rodríguez, M., Rutherford, M. J., West, R. M., Hall, M., Timmis, A., Lindahl, B., Fox, K. A. A., Hemingway, H., et al. (2019) · Cardiovascular Research · doi:10.1093/cvr/cvz197 · Cited by 52
Marqués, M., Kumar, A., Cortés, I., Gonzalez-García, A., Hernández, C., Moreno-Ortiz, M. C., & Carrera, A. C. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01786-07 · Cited by 51
Cui, S., Liu, Z., Tao, B., Fan, S., Pu, Y., Meng, X., Li, D., Xia, H., & Xu, L. (2020) · Journal of Cellular Biochemistry · doi:10.1002/jcb.29843 · Cited by 51
MicroRNAs as Potential Pharmaco-Targets in Ischemia-Reperfusion Injury Compounded by Diabetes
Dehaini, H., Awada, H., EL‐Yazbi, A. F., Zouein, F. A., Issa, K., Eid, A. A., Ibrahim, M., Badran, A., Baydoun, E., Pintus, G., et al. (2019) · Cells · doi:10.3390/cells8020152 · Cited by 50
Tanigaki, K., Mineo, C., Yuhanna, I. S., Chambliss, K. L., Quon, M. J., Bonvini, E., & Shaul, P. W. (2009) · Circulation Research · doi:10.1161/circresaha.108.192906 · Cited by 49 · cited 1×
“in their studies on mice (C57BL/6) showed that CRP attenuates insulin-induced Akt phosphorylation in endothelial cells [161].”
BackgroundLiu, Y., Zhou, Z., & Chen, P. (2007) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2007.04814.x · Cited by 49 · cited 1×
“They administered hydroxysafflor yellow A (HSYA), a chemical compound with a previously noticed protective effect [85,86], during reperfusion.”
BackgroundMyocardial therapeutic angiogenesis: a review of the state of development and future obstacles
Robich, M. P., Chu, L. M., Oyamada, S., Sodha, N. R., & Sellke, F. W. (2011) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.11.148 · Cited by 49 · cited 1×
“As angiogenesis has such a cardioprotective potential in the early stages after MI, therapies focused on the PI3K/Akt pathway have become a novel treatment strategy for patients after infarction [217,222].”
BackgroundYang, L., Li, Y., Wang, X., Mu, X., Qin, D., Huang, W. C., Alshahrani, S., Nieman, M. L., Peng, J., Essandoh, K., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.715805 · Cited by 49 · cited 1×
“miR-223 up [310,317,318] Inhibits angiogenic function of CMECs by decreasing the PI3K/Akt signal activity [319], regulates cardiac hypertrophy by modulating the p-Akt activation [320], and mediates cardiac fibrosis after MI targeting RASA1 expression, which promotes MEK1/2, ERK1/2 and AKT phosphorylation [321].”
BackgroundZhang, S., Zhao, L., Shen, L., Xu, D., Huang, B., Wang, Q., Lin, J., Zou, Y., & Ge, J. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.244970 · Cited by 48 · cited 1×
“It has been noticed that PI3K/Akt plays a pivotal role in activating angiogenesis and in forming collateral circulation via, among others, regulating the transcription and expression of proangiogenic cytokines such as vascular VEGF, angiopoietin-1 (Ang-1), and bFGF (which in addition reverse-stimulates Akt phosphoryla…”
BackgroundVahtola, E., Louhelainen, M., Forstén, H., Merasto, S., Raivio, J., Kaheinen, P., Kytö, V., Tikkanen, I., Levijoki, J., & Mervaala, E. (2010) · Cardiovascular Diabetology · doi:10.1186/1475-2840-9-5 · Cited by 48 · cited 1×
“showed that pronounced cardiomyocyte hypertrophy, increased fibrosis, and cardiomyocyte apoptosis in diabetic rats 12 weeks after MI were associated with decreased Akt activation and increased nuclear localization of FOXO3a (forkhead box O3) [257].”
Cheng, X., Hu, J., Ya, W., Ye, H., Li, X., Gao, Q. F., & Li, Z. (2018) · Journal of Diabetes Research · doi:10.1155/2018/3071959 · Cited by 48 · cited 1×
“Other studies indicate that impairment of PI3K/Akt signaling results in decreased activity of its downstream effector, GSK-3β, leading to ineffective cardioprotection [247,248].”
BackgroundEarly embryonic lethality in mice deficient in the p110β catalytic subunit of PI 3-kinase
Bi, L., Okabe, I., Bernard, D. J., et al. (2002) · Mammalian Genome · doi:10.1007/s00335-001-2123-x · Cited by 48
Cao, W., Xie, Y., Li, X., Zhang, X., Chen, Y.-T., Kang, R., Chen, X., Miao, S., & Wang, S. (2011) · Basic Research in Cardiology · doi:10.1007/s00395-011-0199-3 · Cited by 47 · cited 1×
“a reduction in the number of cardiomyocytes undergoing apoptosis in the infarcted tissue compared with the myocardium where this pathway is inhibited [61,62,65].”
BackgroundZheng, K., Zhang, Q., Lin, G., Li, Y., Sheng, Z.-Q., Wang, J., Chen, L., & Lu, H.-H. (2017) · Oncotarget · doi:10.18632/oncotarget.14785 · Cited by 47
Toulany, M., Maier, J., Iida, M., Rebholz, S., Holler, M., Grottke, A., Jücker, M., Wheeler, D. L., Rothbauer, U., & Rodemann, H. P. (2017) · Cell Death Discovery · doi:10.1038/cddiscovery.2017.72 · Cited by 47 · cited 1×
“Its three isoforms are distinguished, namely Akt1, Akt2, and Akt3 (also known as PKBa, PKBb, and PKBc, respectively) [38,39].”
BackgroundHu, S., Chang, X., Zhu, H., Wang, D., & Chen, G. (2020) · Cytokine · doi:10.1016/j.cyto.2020.155046 · Cited by 47 · cited 1×
“Inhibition of both PI3K (its catalytic subunit p110α) and Akt in mouse fibrosarcoma L929 led to the inhibition of necroptosis by the suppression of the above mediators [95].”
BackgroundYan, L., Guo, N., Cao, Y., Zeng, S., Wang, J., Lv, F., Wang, Y., & Cao, X. (2018) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2018.3748 · Cited by 47
Kwak, D., Choi, S., Jeong, H., Jang, J., Lee, Y., Jeon, H., Lee, M. N., Noh, J., Cho, K., Yoo, J. S., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.326538 · Cited by 46
Takahashi, T., Anzai, T., Kaneko, H., Mano, Y., Anzai, A., Nagai, T., Kohno, T., Maekawa, Y., Yoshikawa, T., Fukuda, K., et al. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00001.2010 · Cited by 46
Guo, X., Hu, S., Liu, J., Huang, L., Zhong, P., Fan, Z., Ye, P., & Chen, M. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15953 · Cited by 46 · cited 2×
“[111] indicated that the radioprotective 105 kD protein (RP105)/ PI3K/Akt pathway is directly involved in the regulation of pyroptosis.”
BackgroundMather, A. N., Fairbairn, T. A., Artis, N. J., Greenwood, J. P., & Plein, S. (2011) · International Journal of Cardiology · doi:10.1016/j.ijcard.2011.11.004 · Cited by 45 · cited 1×
“CRP concentration increases significantly in the first hours of MI [131,154], and its level is a clinically important predictor of the course of left ventricular remodeling and patient prognosis [155,156].”
BackgroundJi, D. B., Zhu, M. C., Zhu, B., Zhu, Y. Z., Li, C. L., Jia, Y., & Zhu, H. (2008) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e318181fb02 · Cited by 44 · cited 1×
“They administered hydroxysafflor yellow A (HSYA), a chemical compound with a previously noticed protective effect [85,86], during reperfusion.”
BackgroundYang, C. D., Shen, Y. H., Lu, L., Ding, F. H., YANG, Z. K., Zhang, R., Shen, W. F., Jin, W., & Wang, X. Q. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0904-3 · Cited by 44 · cited 1×
“They observed greater LV dilation after STEMI among patients with impaired fasting glucose (IFG), impaired glucose tolerance (IGT), and high HOMA-IR levels, who underwent primary percutaneous coronary intervention and were followed up for 12 months [253].”
BackgroundLiu, Y., Zhang, S., Xue, J., Wei, Z., Ao, P., Shen, B., & Ding, L. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/2053149 · Cited by 44 · cited 1×
“Moreover, the use of the PI3K inhibitor LY2994002 abolished these positive effects [84,166,167].”
BackgroundShah, A. M., Hung, C., Shin, S., Skali, H., Verma, A. K., Ghali, J. K., Køber, L., Velazquez, E. J., Rouleau, J. L., McMurray, J. J. V., et al. (2011) · American Heart Journal · doi:10.1016/j.ahj.2011.07.015 · Cited by 42
Modulation of Bax and mTOR for Cancer Therapeutics
Li, R., Ding, C., Zhang, J., Xie, M., Park, D., Ding, Y., Chen, G., Zhang, G., Gilbert‐Ross, M., Zhou, W., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2356 · Cited by 42 · cited 1×
“Bax can also be phosphorylated at residue S184 directly by Akt, which inhibits its conformational change for mitochondrial membrane distribution [76,77].”
BackgroundEnhanced Inflammation is a Marker for Risk of Post-Infarct Ventricular Dysfunction and Heart Failure
Świątkiewicz, I., Magielski, P., Kubica, J., Zadourian, A., DeMaria, A. N., & Taub, P. R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030807 · Cited by 42
miR‐19b controls cardiac fibroblast proliferation and migration
Zhong, C., Wang, K., Liu, Y., Lv, D., Zheng, B., Zhou, Q., Sun, Q., Chen, P., Ding, S., Xu, Y., et al. (2016) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12858 · Cited by 41 · cited 1×
“miR-19 MiR-19a protects H9C2 cardiomyocytes against H/R-induced apoptosis by inhibiting PTEN [292]; MiR-19b promotes NRCFs proliferation and migration by targeting PTEN [293].”
BackgroundZeng, B., Liu, L., Liao, X., Zhang, C., & Ruan, H. (2019) · Experimental Cell Research · doi:10.1016/j.yexcr.2019.05.003 · Cited by 41
Bcl‐2 Is Involved in Cardiac Hypertrophy through PI3K‐Akt Pathway
Meng, X., Cui, J., & He, G. (2021) · BioMed Research International · doi:10.1155/2021/6615502 · Cited by 40 · cited 1×
“[214], on the other hand, found that the PI3K/Akt pathway in mice (C57BL/6J) is involved in the development of hypertrophy by means of yet another molecule, the aforementioned BCL-2, as it maintains cardiomyocyte survival.”
BackgroundRuan, Y., Jin, Q., Zeng, J., Ren, F., Xie, Z.-Y., Ji, K., Wu, L., Wu, J., & Li, L. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.585984 · Cited by 39 · cited 2×
“Activation of the PI3K/Akt pathway may significantly increase cardiac dysfunction when its inhibition has the reverse effect, and increases fibrosis in the infarcted area [66].”
BackgroundMa, Y., Chen, Z., Zou, Y., & Ge, J. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/148798 · Cited by 38 · cited 1×
“showed that the PI3K/Akt/Nrf2 pathway plays a role in attenuating inflammatory cells [165].”
BackgroundPI3K/AKT Pathway Mediates Induction of IL-1RA by TSH in Fibrocytes: Modulation by PTEN
Li, B., & Smith, T. J. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1257 · Cited by 38
Świątkiewicz, I., Koziński, M., Magielski, P., Fabiszak, T., Sukiennik, A., Navarese, E. P., Odrowąż‐Sypniewska, G., & Kubica, J. (2012) · Mediators of Inflammation · doi:10.1155/2012/250867 · Cited by 38 · cited 2×
“CRP concentration increases significantly in the first hours of MI [131,154], and its level is a clinically important predictor of the course of left ventricular remodeling and patient prognosis [155,156].”
BackgroundXiao, Z., Peng, J., Gan, N., Arafat, A., & Yin, F. (2016) · NeuroImmunoModulation · doi:10.1159/000460254 · Cited by 38
Sun, N., Meng, F., Xue, N., Pang, G., Wang, Q., & Ma, H. (2013) · Cardiology Journal · doi:10.5603/cj.a2017.0105 · Cited by 38 · cited 2×
“These effects are positively related to the activation of PI3K/Akt and expression of SGK1 (serum- and glucocorticoid-regulated kinase (1)—a downstream effector of PI3K associated with cell survival [285].”
BackgroundAn, S., Wang, X., Huairui, S., Zhang, X., Meng, H., Li, W., Chen, D., & Ge, J. (2020) · Aging · doi:10.18632/aging.104106 · Cited by 38 · cited 19×
“The impact of the PI3K/Akt signal on the Notch1/Hes1 pathway and its beneficial effect on the diabetic myocardium after IRI was also presented by other researchers [240].”
BackgroundInfluentialMitochondrial Kinases and the Role of Mitochondrial Protein Phosphorylation in Health and Disease
Kotrasová, V., Keresztesová, B., Ondrovičová, G., Bauer, J., Havalová, H., Pevala, V., Kutějová, E., & Kunová, N. (2021) · Life · doi:10.3390/life11020082 · Cited by 38
Colombo, F., Noël, J., Mayers, P., Mercier, I., & Calderone, A. (2001) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2001.1381 · Cited by 37
Prediction of long-term outcome after acute myocardial infarction using circulating miR-145
Dong, Y., Liu, X., Wei, G., Da, Y.-N., Cha, L., & Ma, C. (2014) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365513.2014.981855 · Cited by 37 · cited 1×
“0012]) during the one-year follow-up period [290].”
Yang, Q., Yang, K., & Li, A.-Y. (2015) · PubMed · Cited by 37
Durham, K. K., Chathely, K. M., & Trigatti, B. L. (2018) · Biochemical Journal · doi:10.1042/bcj20170703 · Cited by 37
C-Reactive Protein as a Risk Marker for Post-Infarct Heart Failure over a Multi-Year Period
Świątkiewicz, I., Magielski, P., & Kubica, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22063169 · Cited by 37
Milano, G., Abruzzo, P. M., Bolotta, A., Marini, M., Terraneo, L., Ravara, B., Gorza, L., Vitadello, M., Burattini, S., Curzi, D., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076659 · Cited by 36 · cited 1×
“It was associated with an increased capillary network in the myocardium and improved cardiac function, as well as reduced infarct size [128].”
BackgroundOxidative stress on cardiotoxicity after treatment with single and multiple doses of doxorubicin
Segredo, M. P. D. F., Salvadori, D. M. F., Rocha, N. S., Moretto, F. F., Corrêa, C. R., de Camargo, E. A., de Almeida, D., Reis, R. A. S., Freire, C. M., Braz, M. G., et al. (2013) · Human & Experimental Toxicology · doi:10.1177/0960327113512342 · Cited by 36 · cited 1×
“Activation of the PI3K/Akt pathway using 30 μM 740Y-P resulted in a reversal of the deleterious effects of DOX and LAP and increased survival of the H9c2 cardiomyocytes [105,106].”
MethodThe relevance of microRNA in post-infarction left ventricular remodelling and heart failure
Dutka, M., Bobiński, R., & Korbecki, J. (2019) · Heart Failure Reviews · doi:10.1007/s10741-019-09770-9 · Cited by 36
Choi, H.-W., Shin, P.-G., Lee, J., Choi, W., Kang, M., Kong, W., Oh, M., Seo, Y.-B., & Kim, G. (2017) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2017.3309 · Cited by 35
miR-34a-5p aggravates hypoxia-induced apoptosis by targeting ZEB1 in cardiomyocytes
Shi, K., Sun, H., Zhang, H., Xie, D., & Yu, B. (2018) · Biological Chemistry · doi:10.1515/hsz-2018-0195 · Cited by 35
Can miR-145-5p be used as a marker in diabetic patients?
Shahrokhi, S. Z., Saeidi, L., Sadatamini, M., Jafarzadeh, M., Rahimipour, A., & Kazerouni, F. (2020) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2020.1762657 · Cited by 35 · cited 1×
“miR-145 down [312] Inhibits cardiac cells apoptosis and ROC activity by enhancing the PI3K/Akt and SGK1 activity [285], promotes autophagy and reduces myocardial infarct size targeting FRS2 and inducing PI3K/Akt/mTOR activity [286,287], attenuates fibrosis via activation of the Akt/CREB and suppression of the AKT/GSK-…”
BackgroundKuo, H.-M., Lin, C.-Y., Lam, H., Lin, P., Chan, H., Tseng, J.-C., Sun, C., Hsu, T.-F., Wu, C., Yang, C., et al. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.08.067 · Cited by 33 · cited 1×
“Moreover, overexpression of PTEN (PI3K/Akt inhibitor) attenuates these positive effects and, for example, inhibits angiogenesis and contributes to thrombosis by inducing endothelial dysfunction [218,219].”
BackgroundTai, W., Shi, E., Yan, L., Jiang, X., Ma, H., & Ai, C. (2012) · Journal of Surgical Research · doi:10.1016/j.jss.2012.02.021 · Cited by 33
Nakatani, D., Sakata, Y., Mizuno, H., Shimizu, M., Suna, S., Usami, M., Ito, H., Yasumura, Y., Hirayama, A., Takeda, H., et al. (2009) · Circulation Journal · doi:10.1253/circj.cj-08-0579 · Cited by 31
Qin, Q., Cui, L., Zhou, Z., Zhang, Z., Wang, Y., & Zhou, C. (2019) · Medical Science Monitor · doi:10.12659/msm.916361 · Cited by 31
Li, G., Yang, J., Zhao, G., Shen, Z., Yang, K., Tian, L., Zhou, Q., Chen, Y., & Huang, Y. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16318 · Cited by 31 · cited 1×
“Studies on the impact of the PI3K/Akt pathway on ferroptosis and cardiomyocyte viability are limited [107,108].”
BackgroundDistinct cardioprotective mechanisms of immediate, early and delayed ischaemic postconditioning
Barsukevich, V. C., Васильевна, Б. М., Sanchez, J., Mrochek, A., Whittle, J., Ackland, G. L., Gourine, A. V., & Gourine, A. V. (2014) · Basic Research in Cardiology · doi:10.1007/s00395-014-0452-7 · Cited by 30 · cited 1×
“Immediate IC (10 s of reperfusion) increases phosphorylation of PI3K-AKT and ERK1/2, while early or delayed IC (applied after 10 min or 30 min of reperfusion) had no effect on phosphorylation in the rat model [125].”
MethodWei, K., Liu, L., Xie, F., Hao, X., Luo, J., & Min, S. (2014) · International Journal of Medical Sciences · doi:10.7150/ijms.10101 · Cited by 30 · cited 1×
“The key cytokine involved in sympathetic remodeling following MI is the nerve growth factor (NGF), part of the NGF/TrKA/PI3K/Akt pathway that regulates neuronal plasticity and survival [227,228].”
BackgroundA small molecule activator of AKT does not reduce ischemic injury of the rat heart
Moreira, J. M. A., Wohlwend, M., Alves, M. N. M., Wisløff, U., & Bye, A. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0444-x · Cited by 29
Bellis, A., Gioia, G. D., Mauro, C., Mancusi, C., Barbato, E., Izzo, R., Trimarco, B., & Morisco, C. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10132968 · Cited by 29 · cited 1×
“This ultimately results in cardiac hypertrophy (CH) and heart failure (HF) [13,133].”
BackgroundZhang, J., & Zhang, X. (2020) · Cell Biochemistry and Function · doi:10.1002/cbf.3578 · Cited by 29
Wang, J., Chen, H., Zhou, Y., Su, Q., Liu, T., Wang, X., & Li, L. (2016) · Cellular Physiology and Biochemistry · doi:10.1159/000438622 · Cited by 28 · cited 1×
“This process was attenuated by atorvastatin treatment, which confirms that this type of lipid-lowering drug can have a positive impact on the survival of cardiomyocytes [87].”
BackgroundEconomic Costs of Cardiovascular Diseases in Poland Estimates for 2015–2017 Years
Mela, A., Rdzanek, E., Poniatowski, Ł. A., Jaroszyński, J., Furtak-Niczyporuk, M., Gałązka-Sobotka, M., Olejniczak, D., Niewada, M., & Staniszewska, A. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01231 · Cited by 28
Zhao, X., Ren, Y. T., Ren, H., Wu, Y., Liu, X., Chen, H., & Ying, C. (2021) · Journal of International Medical Research · doi:10.1177/03000605211031433 · Cited by 28 · cited 2×
“[205] in their research on human cardiac fibroblasts (HCF) and rats (C57BL/6) have noticed that the activation of the PI3K/Akt pathway by myocardial infarction-associated transcript (MIAT) promotes myocardial fibrosis and the expression of various inflammatory factors such as IL-1β, IL-6, and TNF-α mRNA, and numerous…”
BackgroundZhao, S.-M. (2017) · The Chinese Journal of Physiology · doi:10.4077/cjp.2017.baf434 · Cited by 25 · cited 1×
“Moreover, the use of the PI3K inhibitor LY2994002 abolished these positive effects [84,166,167].”
BackgroundGao, S., Wang, R., Dong, S., Wu, J., Perek, B., Xia, Z., Yao, S., & Wang, T. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/6657529 · Cited by 25 · cited 1×
“Alteration of this pathway was observed in STZ-induced diabetic mice and cardiac cells exposed to high glucose in vitro [245].”
BackgroundLi, S., Ming-shuang, W., Ke, W.-L., & Wang, M.-R. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.10242 · Cited by 25 · cited 19×
“The impact of the PI3K/Akt signal on the Notch1/Hes1 pathway and its beneficial effect on the diabetic myocardium after IRI was also presented by other researchers [240].”
BackgroundInfluentialPan, Q., Xie, X., Guo, Y. H., & Wang, H. (2013) · Cell Biology International · doi:10.1002/cbin.10236 · Cited by 24 · cited 1×
“In addition, it was shown that this pathway can be important in some pleiotropic effects of statins, such as improvement of endothelial function (defined as increased NO production), increases in proliferation and migration, and reduction in apoptosis of cardiac microvascular endothelial cells [79].”
BackgroundFour-microRNA signature for detection of type 2 diabetes
Yan, L., Zhang, X., Xu, F., Fan, Y., Ge, B., Guo, H., & Li, Z.-L. (2020) · World Journal of Clinical Cases · doi:10.12998/wjcc.v8.i10.1923 · Cited by 24 · cited 1×
“miR-223 up [310,317,318] Inhibits angiogenic function of CMECs by decreasing the PI3K/Akt signal activity [319], regulates cardiac hypertrophy by modulating the p-Akt activation [320], and mediates cardiac fibrosis after MI targeting RASA1 expression, which promotes MEK1/2, ERK1/2 and AKT phosphorylation [321].”
BackgroundWu, X., Li, Y., Baohua, M., & Li, D. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s298735 · Cited by 24 · cited 1×
“miR-375 up [323,324] Exacerbates inflammation and cardiomyocyte apoptosis, decreases angiogenesis and impairs the LV function after MI by a reduction in PDK-1 expression, which results in decreased Akt Thr-308 phosphorylation [325,326].”
BackgroundGuo, X., Li, X., Hu, S., Gang, W., Zhen, C., Ji-Jun, L., Ye, P., & Chen, M. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2019.105910 · Cited by 23
Zhang, Y., Xu, Y., Zhou, K., Kao, G., & Xiao, J. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.11065 · Cited by 23 · cited 1×
“Overexpression of miR-126 enhances viability, migration and tube-forming ability of EPCs, which can play important role in vascular integrity and repair after MI [279].”
BackgroundSchisandrin A protects against isoproterenol‑induced chronic heart failure via miR‑155
Gao, L., Li, T., Li, S., Song, Z.-H., Chang, Y., & Li, Y. (2021) · Molecular Medicine Reports · doi:10.3892/mmr.2021.12540 · Cited by 22 · cited 1×
“miR-155 up [313,314] Targets IKKi expression decreasing its cardioprotective role in activating Akt and NF-κB, independent of the PI3K, and enhances cardiac hypertrophy [315], inhibits the AKT/CREB pathway signal and impairs the left ventricle function [316].”
BackgroundSu, F., Zhao, L., Zhang, S., Wang, J., Chen, N., Gong, Q., Tang, J., Wang, H., Yao, J., Wang, Q., et al. (2015) · Laboratory Investigation · doi:10.1038/labinvest.2015.64 · Cited by 21
Baraka, S. A., Tolba, M. F., Elsherbiny, D. A., El‐Naga, R. N., Awad, A. S., & El‐Demerdash, E. (2021) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13535 · Cited by 21 · cited 1×
“The authors observed the simultaneous activation of the PI3K/Akt pro-survival pathway [83].”
BackgroundWang, L., Tian, X., Cao, Y., Ma, X., Shang, L., Li, H., Zhang, X., Deng, F., Li, S., Guo, T., et al. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.693875 · Cited by 21 · cited 1×
“Therefore, the PI3K/Akt pathway performs a protective effect in post-infarction fibrosis by inhibiting the death of cardiomyocytes [203].”
BackgroundDai, G., Liu, N., Zhu, J., Yao, J., Yang, C., Ma, P.-Z., & Song, X.-B. (2016) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2016/5057328 · Cited by 20 · cited 1×
“miR-223 up [310,317,318] Inhibits angiogenic function of CMECs by decreasing the PI3K/Akt signal activity [319], regulates cardiac hypertrophy by modulating the p-Akt activation [320], and mediates cardiac fibrosis after MI targeting RASA1 expression, which promotes MEK1/2, ERK1/2 and AKT phosphorylation [321].”
BackgroundWang, X., Wang, J., Tu, T., Iyan, Z., Mungun, D., Yang, Z., & Guo, Y. (2018) · BioMed Research International · doi:10.1155/2018/4565630 · Cited by 20 · cited 1×
“Another study showed that remote postconditioning increases phosphorylation of Akt and ERK1/2 in the early stages of reperfusion and then it gradually decreases [126].”
BackgroundTuuminen, R., Holmström, E. J., Raissadati, A., Saharinen, P., Rouvinen, E., Krebs, R., & Lemström, K. (2016) · Transplant Immunology · doi:10.1016/j.trim.2016.05.001 · Cited by 19 · cited 2×
“In addition, it reduced expression of caspase-3 and caspase-9 involved in apoptosis [96].”
BackgroundJiang, Y., Chen, L., Chao, Z., Chen, T., & Zhou, Y. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.817819 · Cited by 19 · cited 2×
“It seems that PI3K/Akt activity may be involved in these processes [109].”
BackgroundLi, C., Shen, S., Wang, T., & Zhang, X. (2015) · PubMed · Cited by 18
Zhan, L., Wang, X., Zhang, Y., Zhu, G., Ding, Y., Chen, X., Jiang, W., & Wu, S. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.10516 · Cited by 18
Teshima, Y., Takahashi, N., Thuc, L. C., Nishio, S., Torigoe, Y., Miyazaki, H., Ezaki, K., Yufu, K., Hara, M., Nakagawa, M., et al. (2010) · Life Sciences · doi:10.1016/j.lfs.2010.06.006 · Cited by 17 · cited 1×
“Another basic study showed that insulin can reduce apoptosis and necrosis by suppressing ROS production, which was also mediated by the PI3K/Akt pathway [262].”
BackgroundLiu, Z., Tao, B., Fan, S., Cui, S., Pu, Y., Qiu, L., Xia, H., & Xu, L. (2020) · Aging · doi:10.18632/aging.103320 · Cited by 17 · cited 2×
“Moreover, it attenuates post-infarct fibrosis and prolonged action potential duration via activation of Akt/CREB cascades, which leads to reduced response to β-adrenergic stimuli [288].”
BackgroundLee, B. S., Kim, S. H., Oh, J., Jin, T., Choi, E. Y., Park, S., Lee, S., Chung, J. H., & Kang, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098113 · Cited by 16 · cited 11×
“Notably, pharmacological blockade of the PI3K/Akt survival pathway by LY294002 completely inhibited angiogenesis induced by CRP/Notch-3.”
BackgroundInfluentialCao, L., & Chai, S. (2020) · Molecular Medicine Reports · doi:10.3892/mmr.2020.11190 · Cited by 16
Chen, X., Zhabyeyev, P., Azad, A. K., Vanhaesebroeck, B., Grueter, C. E., Murray, A. G., Kassiri, Z., & Oudit, G. Y. (2021) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2021.04.004 · Cited by 15
A Unified View of Ventricular Remodelling
Shah, A. M., & Solomon, S. D. (2010) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfq131 · Cited by 14 · cited 1×
“Such structural changes are associated with increased cardiomyocyte apoptosis and fibrosis and result in contractile dysfunction, dilatation, and consequently, the development of HF [207,208].”
BackgroundMahajan, U. B., Patil, P. D., Chandrayan, G., Patil, C. R., Agrawal, Y. O., Ojha, S. K., & Goyal, S. N. (2018) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-018-3276-1 · Cited by 14 · cited 1×
“The reduction in apoptosis activity and the improvement of the hemodynamic function after MI was also reported as an effect of eplerenone and bisoprolol [81,82].”
BackgroundC-reactive protein induces p53-mediated cell cycle arrest in H9c2 cardiac myocytes
Choi, J.-W., Lee, K. H., Kim, S. H., Jin, T., Lee, B. S., Oh, J., Won, H.-Y., Kim, S. Y., Kang, S., & Chung, J. H. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.06.016 · Cited by 13 · cited 1×
“It affects the cell cycle and the inflammatory process of the cardiomyocytes [152,153].”
BackgroundRole of the Beclin 1 Network in the Cross-Regulation Between Autophagy and Apoptosis
Xie, Y., Kang, R., & Tang, D. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802937-4.00002-8 · Cited by 13 · cited 1×
“Moreover, PI3K can also inhibit autophagy directly by phosphorylating Beclin-1, a core component of Beclin 1-PI3KC3 complex, a lipid–kinase complex playing a crucial role in autophagosome nucleation [192].”
BackgroundAkashi, N., Tsukui, T., Yamamoto, K., Seguchi, M., Taniguchi, Y., Sakakura, K., Wada, H., Momomura, S., & Fujita, H. (2021) · Heart and Vessels · doi:10.1007/s00380-021-01827-w · Cited by 13 · cited 1×
“023) after STEMI, and left ventricular remodeling at the baseline was an independent risk factor [252].”
BackgroundMajka, M., Kleibert, M., & Wojciechowska, M. (2021) · Cells · doi:10.3390/cells10123331 · Cited by 12 · cited 1×
“This can be associated with the increased vulnerability of the heart to ischemic injury or the adverse post-MI remodeling of the left ventricle [268].”
BackgroundSelf-citationWang, J., Liu, J., Xie, L., Cai, X.-M., Ma, X., & Gong, J.-B. (2020) · Fundamental & Clinical Pharmacology · doi:10.1111/fcp.12562 · Cited by 11
Guo, X., Jiang, H., & Chen, J. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.01.100 · Cited by 10
Li, S.-S., Kang, N., Li, X., Yuan, J., Ling, R., Li, P., & Li, J.-L. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/5536406 · Cited by 9 · cited 1×
“showed that the appropriate regulation of the PI3K/Akt pathway by inhibiting its excessive activity reduces the abnormal excitability, automatism, and conductivity of residual myocytes, which result in the initiation of arrhythmia after myocardial infarction in rats [229,230].”
BackgroundYan, M., Liu, Q., Jiang, Y., Wang, B., Ji, Y., Liu, H., & Xie, Y. (2020) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000845 · Cited by 8 · cited 1×
“miR-375 up [323,324] Exacerbates inflammation and cardiomyocyte apoptosis, decreases angiogenesis and impairs the LV function after MI by a reduction in PDK-1 expression, which results in decreased Akt Thr-308 phosphorylation [325,326].”
BackgroundYu, T.-S., Ge, L. Z., & Cao, J. (2019) · PubMed · doi:10.12116/j.issn.1004-5619.2019.01.013 · Cited by 4 · cited 1×
“Such arrhythmias are the result of sympathetic remodeling, a phenomenon of disturbance of the spatial distribution and density of the myocardial sympathetic innervation caused by denervation in the infarcted zone and hyperinnervation in the infarcted border zone [224,225].”
Background
Research works printed but not linked: 1
- Yan, 2018, miRNA145 inhibits myocardial infarctioninduced apoptosis through autophagy via Akt3/mTOR signaling pathway in vitro and in vivo, Int. J. Mol. Med., 42, 1537
Cited by
Glucagon-like peptide-1 receptor: mechanisms and advances in therapy
Zheng, Z., Zong, Y., Ma, Y., Tian, Y., Pang, Y., Zhang, C., & Gao, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01931-z · Cited by 1,036
“437,438 This involves modulating the cell apoptosis process, for example, by decreasing the Bax/Bcl-2 ratio in cardiomyocytes, reducing cytochrome C release, and caspase activation.”
BackgroundHypertensive heart disease: risk factors, complications and mechanisms
Masenga, S. K., & Kirabo, A. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1205475 · Cited by 216
Regulation of bone homeostasis: signaling pathways and therapeutic targets
Wu, Z., Li, W., Jiang, K., Lin, Z., Qian, C., Wu, M., Xia, Y., Li, N., Zhang, H., Xiao, H.-X., et al. (2024) · MedComm · doi:10.1002/mco2.657 · Cited by 151
“158 Among them, the PH structural domain mediates the process of membrane translocation after AKT activation 159 ; the catalytic structural domain contains an ATP-binding site 160 ; and the C-terminal regulatory domain is proline-rich and contains another phosphorylation site, Ser473.”
BackgroundLiu, X., Li, D., Pi, W., Wang, B., Xu, S., Yu, L., Yao, L., Sun, Z., Jiang, J., & Mi, Y. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109379 · Cited by 90
Song, M., Choi, D. B., Im, J. S., Song, Y. N., Kim, J. H., Lee, H., An, J., Kim, A., Choi, H. G., Kim, J., et al. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06703-9 · Cited by 92
“…responses associated with IR injury and myocardial infarction [56] Thus, we presume that the increased population of endothelial cells in HOs may contribute to the more sensitive responses to hypoxia-induced apoptosis and the heightened production of in fl ammatory factors observed after IR injury.”
Background
Metadata
- Authors
- Walkowski, B., Kleibert, M., Majka, M., & Wojciechowska, M.
- Affiliations
- Medical University of Warsaw (PL)
- Corresponding author
- Kleibert, Marcin
- Majka, Miłosz
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2022-05-05
- Volume
- 11
- Issue
- 9
- Pages
- 1553
- ISSN
- 2073-4409 (ISSN-L)
- PMC
- PMC9105930
- OpenAlex
- W4280571486
- Cited by
- 117
- References
- 340
- Citations by year
- 2026: 27 · 2025: 31 · 2024: 28 · 2023: 28 · 2022: 3
- FWCI
- 4.58
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Cells (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- Publishing Fund of the Medical University of Warsaw (1MA/N/2022)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Ischemia and Reperfusion
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Keywords
- PI3K/Akt signaling, myocardial ischemia, myocardial infarction, diabetic cardiomyopathy, diabetic heart, cardiomyocyte survival, molecularly targeted agents, antidiabetic drugs, cardiovascular drugs
- MeSH terms
- Diabetes Mellitus, Humans, Myocardial Infarction, Apoptosis, Phosphatidylinositol 3-Kinases, Ventricular Remodeling, Myocytes, Cardiac, Proto-Oncogene Proteins c-akt
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.